Phospholipase A2 inhibits nuclear nucleoside triphosphatase activity and mRNA export in isolated nuclei from rat liver.
The present study is undertaken to investigate whether the phospholipase A(2) (PLA(2)) influences mRNA nucleocytoplasmic transport evaluated by nucleoside triphosphatase (NTPase) activity and mRNA export in isolated hepatic nuclear envelope. Isolated hepatic nuclei from rat liver were exposed to PLA(2) (10(-5) approximately 10(-2)/ml) with or without incorporation of nuclei with phosphatidylcholine (PC) liposome. Messenger RNA exports and NTPase activities of nuclear membrane were assayed using ATP and GTP as substrates. We found that the RNA efflux, evaluated by [3H] uridine, was potently decreased in a concentration-dependent manner, by incubation of hepatic nuclei with PLA(2), regardless using ATP or GTP as substrates. The PC content in nuclear membrane was also decreased by PLA(2)-treatment. The PC was incorporated into the nuclear membrane by addition of phospholipid liposomes into the incubation mixture. PC incorporation into the nuclear membrane did not alter mRNA export. However this resulted in a significant increase in mRNA export rate in PLA(2)-treated group. Messenger RNA export rate in PLA(2) (10(-3) unit/mL)- treated nuclear membrane was positively correlated with level of PC incorporation, both using ATP and GTP as substrates. The activity of nucleoside triphosphatase, a nuclear membrane-associated enzyme, showed parallel variations with mRNA transport. It is concluded that nuclear PLA(2) plays a regulatory role in RNA transport, which can be antagonized by exogenous PC. These might be pathophysiologically significance, although the mechanisms by which this effect takes place remain to be clarified.
Li
Ju-Xiang
JX
Department of Physiology and Pathophysiology, Health-Science Center, Peking University, Beijing 100083, China. juxiangli@hotmail.com
Li
Zai-Quan
ZQ
Pang
Yong-Zheng
YZ
Tang
Chao-Shu
CS
D017766:Acid Anhydride Hydrolases / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D015415:Biomarkers; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology*; D003593:Cytoplasm / Q000187:drug effects / Q000201:enzymology; D007425:Intracellular Membranes / Q000378:metabolism; D050356:Lipid Metabolism; D008081:Liposomes; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D043583:Nucleoside-Triphosphatase; D010713:Phosphatidylcholines / Q000378:metabolism; D010741:Phospholipases A / Q000494:pharmacology*; D054467:Phospholipases A2; D012333:RNA, Messenger / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley
D015415:Biomarkers; D008081:Liposomes; D010713:Phosphatidylcholines; D012333:RNA, Messenger; D010741:Phospholipases A; D054467:Phospholipases A2; D017766:Acid Anhydride Hydrolases; D000251:Adenosine Triphosphatases; D043583:Nucleoside-Triphosphatase